With this investment, FIIs now hold a 1.45 per cent stake in the company.

The stock gave multibagger returns of 123.50 per cent from its 52-week low of Rs 515.40 per share.

From Rs 1.90 to Rs 84.90 per share, the stock delivered multibagger returns of over 4,300 per cent in 3 years.

Raising stakes by DIIs and FIIs in various stocks often acts as a positive signal for potential growth opportunities.

The shares of the company have a PE of 62.6x, an ROE of 25.3 per cent and an ROCE of 30.3 per cent.

Raising stakes by Mutual Funds in various stocks often acts as a positive signal for retail investors for potential growth opportunities.

The stock gave multibagger returns of 170 per cent in just 1 year whereas BSE Small-cap Index is 43.8 per cent and a whopping 870 per cent in 3 years.

The stock gave multibagger returns of over 100 per cent in just 6 months whereas BSE Small-Cap Index is up by 30 per cent.

The stock gave multibagger returns of 185 per cent in just 1 year, 750 per cent in 2 years and a whopping 1,500 per cent in 3 years.

The stock gave multibagger returns of 127.5 per cent from its 52-week low of Rs 13.1 per share.

The stock gave multibagger returns of 450 per cent in just 1 year and a whopping 1,000 per cent in 3 years. 

FII stake increase: Foreign Institutional Investors (FIIs) have increased their stake in Lincoln Pharma from 0.63 per cent in September 2022 to 2.59 per cent in September 2023.

Promoter holding increase: The promoter holding in Lincoln Pharma has also increased from 44.09 per cent in September 2022 to 50.53 per cent in September 2023.

In the previous financial year 2022-2023, the company had declared bonus shares in the ratio 4:1 and stock split from a face value of Rs 5 to a face value of Rs 1. The stock split record date was August 28, 2022 and the bonus shares record date was January 06, 2023.

In Q4FY23, the company witnessed a remarkable surge in net sales, soaring by 1,345 per cent to Rs 33.98 crore, and net profit experienced an astonishing growth of 2,414 per cent, reaching Rs 1.92 crore compared to Q4FY22. Similarly, for the entire FY23, net sales rose by 918 per cent to Rs 506.62 crore, and net profit skyrocketed by 1,047 per cent to Rs 2.01 crore compared to FY22.

The stock delivered a multibagger return of 135.38 per cent in just six months, while the BSE Sensex gained only 17.84 per cent.

Indices witnessed selling pressure towards the end as Nifty closed above the 17,800 level. The benchmark index jumped 1.10 per cent while BSE Sensex climbed 578 points.

Indices ended higher after a volatile second half as Nifty rose 36 points or 0.21 per cent while Sensex jumped nearly 60 points. Nifty Midcap and Nifty Smallcap climbed 0.70 per cent & 0.55 per cent, respectively.  

Indices were on a free fall in the last half an hour as Nifty collapsed over 200 points to close at 17,505.